{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/SHPH",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Shuttle Pharmaceuticals Holdings, Inc., listed on NASDAQ under ticker SHPH. The ISIN is not on the record, and the LEI is not on the record. The security type is Corporate, the segment is not on the record, and the sector is 2834 Pharmaceutical Preparations. The jurisdiction is United States, Delaware. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 63 filings in the twelve months to 2026-11-08, across 48 filing days. The median gap between filing days is 5 days. The latest filing is dated 2026-11-06, two days before the record date, and is of type director_change. The exchange median for NASDAQ is 5.0 days of latency and 6.0 days of cadence gap, across 52 median filings. The sector median for 2834 Pharmaceutical Preparations is 4.0 days of latency and 6.0 days of cadence gap, across 63.0 median filings. The issuer's filings are 63, which is equal to the sector median, and its latency of 2 days is below both the exchange and sector medians. The filings by type are: 13 regulatory_filing, 10 directors_dealings, 9 agm_egm, 9 corporate_news, 6 prospectus, 5 director_change, 5 results, 3 ad_hoc, 2 halt_suspension, and 1 takeover.\n\n## Auditor\n\nThe auditor of record is Forvis Mazars, LLP, located in Atlanta, Georgia. The record carries one auditor change, dated 2026-10-22.\n\n## Events and halts\n\nThe record holds no listing, delisting, or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable for this issuer under acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of chapter date 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.\n\n## Coverage\n\nNo research houses were found on the investor-relations pages read. The count is 0.\n\n## Open research\n\nNo openly published research notes were found. The count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe issuer's sealed years are 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://data.sec.gov/submissions/CIK0001757499.json (identity.jurisdiction)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/SHPH (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://www.sec.gov/Archives/edgar/data/1757499/000149315226014131/form10-k.htm (the auditor)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/SHPH (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1757499/000149315226014131/form10-k.htm",
    "state": "sourced",
    "value": "Forvis Mazars, LLP"
   },
   "auditor_firm_id": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1757499/000149315226014131/form10-k.htm",
    "state": "sourced",
    "value": "686"
   },
   "auditor_location": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1757499/000149315226014131/form10-k.htm",
    "state": "sourced",
    "value": "Atlanta,\nGeorgia"
   },
   "changes": [
    {
     "date": "2026-10-22",
     "source": "https://www.sec.gov/Archives/edgar/data/1757499/000149315226048112/form8-k.htm",
     "title": "8-K — 8-K (items 4.01,9.01)"
    }
   ]
  },
  "cmr": "us-cm-kg/NASDAQ/SHPH",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 526,
     "median_cadence_gap_days": 6,
     "median_filings": 63,
     "median_latency_days": 4,
     "name": "2834 Pharmaceutical Preparations"
    }
   },
   "by_type": {
    "ad_hoc": 3,
    "agm_egm": 9,
    "corporate_news": 9,
    "director_change": 5,
    "directors_dealings": 10,
    "halt_suspension": 2,
    "prospectus": 6,
    "regulatory_filing": 13,
    "results": 5,
    "takeover": 1
   },
   "cadence_median_gap_days": 5,
   "filing_days": 48,
   "filings": 63,
   "latency_days": 2,
   "latest": [
    {
     "category": "8-K",
     "date": "2026-11-06",
     "source": "https://www.sec.gov/Archives/edgar/data/1757499/000149315226050532/form8-k.htm",
     "title": "8-K — 8-K (items 4.01,9.01)",
     "type": "director_change"
    },
    {
     "category": "8-K",
     "date": "2026-10-22",
     "source": "https://www.sec.gov/Archives/edgar/data/1757499/000149315226048112/form8-k.htm",
     "title": "8-K — 8-K (items 4.01,9.01)",
     "type": "director_change"
    },
    {
     "category": "10-Q",
     "date": "2026-09-24",
     "source": "https://www.sec.gov/Archives/edgar/data/1757499/000149315226044107/form10-q.htm",
     "title": "10-Q — 10-Q",
     "type": "results"
    },
    {
     "category": "8-K/A",
     "date": "2026-09-24",
     "source": "https://www.sec.gov/Archives/edgar/data/1757499/000149315226044106/form8-ka.htm",
     "title": "8-K/A — 8-K/A (items 9.01)",
     "type": "ad_hoc"
    },
    {
     "category": "8-K",
     "date": "2026-09-16",
     "source": "https://www.sec.gov/Archives/edgar/data/1757499/000149315226042791/form8-k.htm",
     "title": "8-K — 8-K (items 3.02,9.01)",
     "type": "ad_hoc"
    }
   ],
   "latest_filing_date": "2026-11-06",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/SHPH",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "market": "US",
    "reason": "no LEI, so no GLEIF ISIN route; EDGAR carries no ISIN",
    "state": "not_on_record"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001757499.json",
    "state": "sourced",
    "value": "United States — Delaware"
   },
   "lei": {
    "market": "US",
    "reason": "no GLEIF record with the exact legal name in jurisdiction US-DE",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001757499.json",
    "state": "sourced",
    "value": "Shuttle Pharmaceuticals Holdings, Inc."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001757499.json",
    "state": "sourced",
    "value": "2834 Pharmaceutical Preparations"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001757499.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "SHPH"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:e1c64f28eb7c7ac39792ddef3d47a1863afae85d4fccfb9cbbe9a41ac4dfb630",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/SHPH",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:e1c64f28eb7c7ac39792ddef3d47a1863afae85d4fccfb9cbbe9a41ac4dfb630",
 "path": "/us/NASDAQ/SHPH",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Shuttle Pharmaceuticals Holdings, Inc., listed on NASDAQ under ticker SHPH. The ISIN is not on the record, and the LEI is not on the record. The security type is Corporate, the segment is not on the record, and the sector is 2834 Pharmaceutical Preparations. The jurisdiction is United States, Delaware. The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 63 filings in the twelve months to 2026-11-08, across 48 filing days. The median gap between filing days is 5 days. The latest filing is dated 2026-11-06, two days before the record date, and is of type director_change. The exchange median for NASDAQ is 5.0 days of latency and 6.0 days of cadence gap, across 52 median filings. The sector median for 2834 Pharmaceutical Preparations is 4.0 days of latency and 6.0 days of cadence gap, across 63.0 median filings. The issuer's filings are 63, which is equal to the sector median, and its latency of 2 days is below both the exchange and sector medians. The filings by type are: 13 regulatory_filing, 10 directors_dealings, 9 agm_egm, 9 corporate_news, 6 prospectus, 5 director_change, 5 results, 3 ad_hoc, 2 halt_suspension, and 1 takeover.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is Forvis Mazars, LLP, located in Atlanta, Georgia. The record carries one auditor change, dated 2026-10-22.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting, or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable for this issuer under acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of chapter date 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the investor-relations pages read. The count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found. The count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The issuer's sealed years are 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001757499.json"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/SHPH"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the auditor",
   "source": "https://www.sec.gov/Archives/edgar/data/1757499/000149315226014131/form10-k.htm"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/SHPH"
  }
 ],
 "title": "Shuttle Pharmaceuticals Holdings, Inc. (SHPH) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}